| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO4 CACNA1A SCN11A PSG1 PSG3 PSG5 PSG6 TRPC1 RBP4 ABCB6 SLCO1B3 SLC28A3 CLDN4 SLCO1B1 SLC66A1 SIDT2 SLC11A1 KCNT2 SLC22A13 SCN1A SLC16A14 SCN2A SCN3A SCN10A CYB561D1 TRPV4 CACNA1I SLC2A13 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 9.93e-09 | 1180 | 175 | 32 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | ANO4 CACNA1A SCN11A PSG1 PSG3 PSG5 PSG6 TRPC1 RBP4 ABCB6 SLCO1B3 SLC28A3 CLDN4 SLCO1B1 SLC66A1 SIDT2 SLC11A1 KCNT2 SLC22A13 SCN1A SLC16A14 SCN2A SCN3A SCN10A CYB561D1 TRPV4 CACNA1I SLC2A13 M6PR ATP2B1 ATP2B2 ATP2B4 KCNT1 | 2.27e-08 | 1289 | 175 | 33 | GO:0005215 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 8.28e-08 | 26 | 175 | 6 | GO:0005248 | |
| GeneOntologyMolecularFunction | calmodulin binding | CACNA1A PSG1 PSG3 PSG5 PSG6 PHKA2 TJP1 SCN2A SCN3A TRPV4 ATP2B1 ATP2B2 ATP2B4 | 1.27e-07 | 230 | 175 | 13 | GO:0005516 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.76e-07 | 70 | 175 | 8 | GO:1901618 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 4.56e-07 | 34 | 175 | 6 | GO:0015125 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.25e-06 | 90 | 175 | 8 | GO:0008028 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.53e-06 | 73 | 175 | 7 | GO:0170055 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A SCN11A TRPC1 SLC28A3 SLC11A1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I ATP2B1 ATP2B2 ATP2B4 KCNT1 | 3.55e-06 | 465 | 175 | 16 | GO:0046873 |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 4.89e-06 | 29 | 175 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 5.33e-06 | 14 | 175 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | sodium channel activity | 6.06e-06 | 52 | 175 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A SCN11A TRPC1 SLC28A3 SLC11A1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I SLC2A13 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 3.86e-05 | 627 | 175 | 17 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO4 CACNA1A SCN11A TRPC1 SLC28A3 CLDN4 SLC11A1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I SLC2A13 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 3.89e-05 | 758 | 175 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | GPI anchor binding | 4.43e-05 | 23 | 175 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO4 CACNA1A SCN11A TRPC1 SLC28A3 CLDN4 SLC11A1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I SLC2A13 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 7.10e-05 | 793 | 175 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | intracellular sodium-activated potassium channel activity | 7.64e-05 | 2 | 175 | 2 | GO:0005228 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A SCN11A TRPC1 SLC28A3 SLC11A1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I SLC2A13 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 7.83e-05 | 664 | 175 | 17 | GO:0008324 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | PSG1 PSG3 PSG5 PSG6 SLCO1B3 SLCO1B1 SLC66A1 SLC22A13 SLC16A14 | 9.08e-05 | 207 | 175 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | PSG1 PSG3 PSG5 PSG6 SLCO1B3 SLCO1B1 SLC66A1 SLC22A13 SLC16A14 | 9.42e-05 | 208 | 175 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.04e-04 | 11 | 175 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | filamin binding | 1.14e-04 | 29 | 175 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ANO4 CACNA1A SCN11A TRPC1 CLDN4 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I KCNT1 | 2.12e-04 | 459 | 175 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | sodium ion binding | 2.24e-04 | 14 | 175 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | 6-phosphofructokinase activity | 2.28e-04 | 3 | 175 | 2 | GO:0003872 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A SCN11A TRPC1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I KCNT1 | 2.29e-04 | 343 | 175 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.43e-04 | 196 | 175 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.77e-04 | 151 | 175 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 4.11e-04 | 17 | 175 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 5.42e-04 | 210 | 175 | 8 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatase binding | 5.51e-04 | 264 | 175 | 9 | GO:0019902 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 5.78e-04 | 19 | 175 | 3 | GO:0042577 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.09e-04 | 118 | 175 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | fructose-6-phosphate binding | 7.51e-04 | 5 | 175 | 2 | GO:0070095 | |
| GeneOntologyMolecularFunction | channel activity | ANO4 CACNA1A SCN11A TRPC1 CLDN4 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I KCNT1 | 7.57e-04 | 525 | 175 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ANO4 CACNA1A SCN11A TRPC1 CLDN4 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I KCNT1 | 7.70e-04 | 526 | 175 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 7.91e-04 | 171 | 175 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | glycolipid binding | 8.88e-04 | 49 | 175 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | lipid binding | EPHX1 PSG1 PSG3 PSG5 PSG6 ANXA7 RBP4 TLR6 DYSF MAP3K1 EHD3 ARL6 APPL2 CHPT1 SULT2B1 VILL TRPV4 WDFY3 MITD1 | 1.10e-03 | 988 | 175 | 19 | GO:0008289 |
| GeneOntologyMolecularFunction | fructose binding | 1.12e-03 | 6 | 175 | 2 | GO:0070061 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.14e-03 | 182 | 175 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | PSG1 PSG3 PSG5 PSG6 SLCO1B3 SLCO1B1 SLC66A1 SLC22A13 SLC16A14 | 1.15e-03 | 293 | 175 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.21e-03 | 184 | 175 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.48e-03 | 26 | 175 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid phosphatase activity | 1.56e-03 | 7 | 175 | 2 | GO:0052642 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 1.56e-03 | 7 | 175 | 2 | GO:0008443 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.14e-03 | 62 | 175 | 4 | GO:0016796 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.81e-03 | 334 | 175 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 2.85e-03 | 110 | 175 | 5 | GO:0008238 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCB6 SLCO1B3 SLC28A3 SLCO1B1 SLC11A1 SLC16A14 CYB561D1 SLC2A13 ATP2B1 ATP2B2 ATP2B4 | 3.31e-03 | 477 | 175 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.33e-03 | 70 | 175 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 3.82e-03 | 36 | 175 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 3.82e-03 | 36 | 175 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 3.99e-03 | 11 | 175 | 2 | GO:0004301 | |
| GeneOntologyBiologicalProcess | circulatory system process | TBXAS1 EPHX2 SCN11A PSG1 PSG3 PSG5 PSG6 TRPC1 LEPR EHD3 TJP1 PRCP LNPEP SCN1A SCN2A SCN3A SCN10A TRPV4 SLC2A13 IMMP2L ATP2B1 ATP2B2 ATP2B4 | 6.72e-08 | 733 | 175 | 23 | GO:0003013 |
| GeneOntologyBiologicalProcess | blood circulation | TBXAS1 EPHX2 SCN11A PSG1 PSG3 PSG5 PSG6 TRPC1 EHD3 TJP1 PRCP LNPEP SCN1A SCN2A SCN3A SCN10A TRPV4 IMMP2L ATP2B1 ATP2B2 ATP2B4 | 1.54e-07 | 648 | 175 | 21 | GO:0008015 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 5.40e-07 | 36 | 175 | 6 | GO:0086010 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 7.57e-07 | 21 | 175 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 7.57e-07 | 21 | 175 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 2.75e-06 | 47 | 175 | 6 | GO:0015721 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 3.54e-06 | 49 | 175 | 6 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.99e-06 | 50 | 175 | 6 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 4.18e-06 | 29 | 175 | 5 | GO:1903779 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.69e-06 | 14 | 175 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 6.35e-06 | 15 | 175 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 6.35e-06 | 15 | 175 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.35e-06 | 15 | 175 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 6.35e-06 | 15 | 175 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 7.82e-06 | 56 | 175 | 6 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 8.13e-06 | 33 | 175 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 8.42e-06 | 16 | 175 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.09e-05 | 17 | 175 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.09e-05 | 17 | 175 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.09e-05 | 17 | 175 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 1.17e-05 | 60 | 175 | 6 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.23e-05 | 126 | 175 | 8 | GO:1903035 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.40e-05 | 18 | 175 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | amide transport | CWH43 TRPC1 ANXA7 RBP4 SLCO1B3 PFKL PFKM SLCO1B1 LEPR SIDT2 TRPV4 PRKD1 MAP4K4 SMAD2 | 1.47e-05 | 420 | 175 | 14 | GO:0042886 |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.56e-05 | 63 | 175 | 6 | GO:0019228 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 2.03e-05 | 98 | 175 | 7 | GO:0061045 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.18e-05 | 20 | 175 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 2.68e-05 | 21 | 175 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 3.11e-05 | 71 | 175 | 6 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 3.11e-05 | 71 | 175 | 6 | GO:0043114 | |
| GeneOntologyBiologicalProcess | energy homeostasis | 3.23e-05 | 144 | 175 | 8 | GO:0097009 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 3.25e-05 | 22 | 175 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | peptide secretion | CWH43 TRPC1 ANXA7 RBP4 PFKL PFKM LEPR SIDT2 TRPV4 PRKD1 MAP4K4 SMAD2 | 3.83e-05 | 343 | 175 | 12 | GO:0002790 |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 3.85e-05 | 45 | 175 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.91e-05 | 23 | 175 | 4 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.91e-05 | 23 | 175 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 4.12e-05 | 149 | 175 | 8 | GO:0062014 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 4.66e-05 | 24 | 175 | 4 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 4.66e-05 | 24 | 175 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 4.66e-05 | 24 | 175 | 4 | GO:0002420 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 4.77e-05 | 47 | 175 | 5 | GO:0001911 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 4.81e-05 | 112 | 175 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ANO4 CACNA1A SCN11A TRPC1 ABCB6 SLC28A3 CLDN4 DYSF EHD3 SLC11A1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I PRKD1 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 5.26e-05 | 1017 | 175 | 22 | GO:0098660 |
| GeneOntologyBiologicalProcess | peptide transport | CWH43 TRPC1 ANXA7 RBP4 PFKL PFKM LEPR SIDT2 TRPV4 PRKD1 MAP4K4 SMAD2 | 5.34e-05 | 355 | 175 | 12 | GO:0015833 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 5.51e-05 | 25 | 175 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 5.51e-05 | 25 | 175 | 4 | GO:0002423 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 6.71e-05 | 118 | 175 | 7 | GO:0001570 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 7.54e-05 | 27 | 175 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 7.81e-05 | 52 | 175 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 7.86e-05 | 121 | 175 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | wound healing | ERBB3 CLASP1 PSG1 PSG3 PSG5 PSG6 MUC16 CLDN4 ADTRP DYSF MAP3K1 ITPK1 SLC11A1 PRCP | 8.41e-05 | 493 | 175 | 14 | GO:0042060 |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 8.74e-05 | 28 | 175 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 8.84e-05 | 166 | 175 | 8 | GO:0061041 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.01e-04 | 29 | 175 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 1.02e-04 | 217 | 175 | 9 | GO:1903034 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A SCN11A TRPC1 ABCB6 SLC28A3 DYSF EHD3 SLC11A1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I PRKD1 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 1.14e-04 | 922 | 175 | 20 | GO:0098662 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A SCN11A TRPC1 ABCB6 SLC28A3 DYSF HEPH EHD3 SLC11A1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I PRKD1 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 1.19e-04 | 1000 | 175 | 21 | GO:0030001 |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | CLASP1 PSG1 PSG3 PSG5 PSG6 ITGA3 ADTRP APPL2 PRCP SGPL1 ARID5B PRKD1 CTSH MAP4K4 ATP2B4 | 1.25e-04 | 577 | 175 | 15 | GO:0001667 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.32e-04 | 31 | 175 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | TRPC1 ANXA7 RBP4 PFKL PFKM LEPR SIDT2 TRPV4 PRKD1 MAP4K4 SMAD2 | 1.38e-04 | 334 | 175 | 11 | GO:0030072 |
| GeneOntologyBiologicalProcess | chemical homeostasis | SLC25A46 TBXAS1 EPHX2 CACNA1A TRPC1 ANXA7 RBP4 ABCB6 PFKM SLC66A1 LEPR SIDT2 SLC11A1 APPL2 PRCP EHD1 TRPV4 PRKD1 CTSH MAP4K4 ATP2B1 ATP2B2 ATP2B4 SMAD2 | 1.49e-04 | 1249 | 175 | 24 | GO:0048878 |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.50e-04 | 32 | 175 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 1.50e-04 | 32 | 175 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.50e-04 | 32 | 175 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.50e-04 | 32 | 175 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | cell differentiation in hindbrain | 1.50e-04 | 32 | 175 | 4 | GO:0021533 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A SCN11A TRPC1 ABCB6 SLC28A3 DYSF EHD3 SLC11A1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I PRKD1 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 1.51e-04 | 942 | 175 | 20 | GO:0098655 |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | TBXAS1 EPHX1 EPHX2 PSG1 PSG3 PSG5 PSG6 ADTRP LPIN3 CRYL1 APPL2 SLC22A13 SGPL1 | 1.62e-04 | 461 | 175 | 13 | GO:0006631 |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 1.68e-04 | 61 | 175 | 5 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.69e-04 | 33 | 175 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell migration | CLASP1 PSG1 PSG3 PSG5 PSG6 ITGA3 PRCP PRKD1 CTSH MAP4K4 ATP2B4 | 1.78e-04 | 344 | 175 | 11 | GO:0010632 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | TBXAS1 PSG1 PSG3 PSG5 PSG6 LEPR TJP1 TRPV4 SLC2A13 ATP2B1 ATP2B4 | 1.78e-04 | 344 | 175 | 11 | GO:0003018 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.82e-04 | 62 | 175 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.90e-04 | 34 | 175 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.90e-04 | 34 | 175 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | cerebellar cortex formation | 1.90e-04 | 34 | 175 | 4 | GO:0021697 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ANO4 CACNA1A SCN11A TRPC1 ABCB6 SLC28A3 CLDN4 DYSF EHD3 SLC11A1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I PRKD1 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 1.98e-04 | 1115 | 175 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | cardiac conduction | 2.11e-04 | 100 | 175 | 6 | GO:0061337 | |
| GeneOntologyBiologicalProcess | behavior | SLC25A46 CACNA1A SCN11A CWH43 DSCAM PSG1 PSG3 PSG5 PSG6 LRRTM1 ITGA3 LEPR SCN1A SCN2A SCN3A SCN10A SORCS3 ATP2B2 CNP | 2.11e-04 | 891 | 175 | 19 | GO:0007610 |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.13e-04 | 35 | 175 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | cellular detoxification of cadmium ion | 2.14e-04 | 3 | 175 | 2 | GO:0098849 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity directed against tumor cell target | 2.14e-04 | 3 | 175 | 2 | GO:0002852 | |
| GeneOntologyBiologicalProcess | cellular detoxification of metal ion | 2.14e-04 | 3 | 175 | 2 | GO:0140961 | |
| GeneOntologyBiologicalProcess | heart contraction | SCN11A TRPC1 EHD3 SCN1A SCN2A SCN3A SCN10A ATP2B1 ATP2B2 ATP2B4 | 2.40e-04 | 298 | 175 | 10 | GO:0060047 |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 2.43e-04 | 145 | 175 | 7 | GO:0045833 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO4 CACNA1A SCN11A TRPC1 ABCB6 SLCO1B3 SLC28A3 CLDN4 DYSF SLCO1B1 HEPH EHD3 SLC11A1 KCNT2 SCN1A SCN2A SCN3A SCN10A TRPV4 CACNA1I PRKD1 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 2.48e-04 | 1374 | 175 | 25 | GO:0006811 |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | CWH43 TRPC1 ANXA7 RBP4 PFKL PFKM ADTRP CBLN1 LEPR SIDT2 MAP4K4 M6PR SMAD2 | 2.93e-04 | 490 | 175 | 13 | GO:0071692 |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.95e-04 | 38 | 175 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 3.01e-04 | 69 | 175 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | fructose 6-phosphate metabolic process | 3.10e-04 | 16 | 175 | 3 | GO:0006002 | |
| GeneOntologyBiologicalProcess | import into cell | DOCK2 CACNA1A PSG1 PSG3 PSG5 PSG6 MYO1H RBP4 LRRTM1 DYSF LEPR EHD3 SLC11A1 APPL2 CSNK1D EHD1 TRPV4 CACNA1I PRKD1 M6PR ATP2B4 | 3.15e-04 | 1074 | 175 | 21 | GO:0098657 |
| GeneOntologyBiologicalProcess | heart process | SCN11A TRPC1 EHD3 SCN1A SCN2A SCN3A SCN10A ATP2B1 ATP2B2 ATP2B4 | 3.20e-04 | 309 | 175 | 10 | GO:0003015 |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 3.22e-04 | 70 | 175 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 3.27e-04 | 39 | 175 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | epithelial cell migration | CLASP1 PSG1 PSG3 PSG5 PSG6 ITGA3 ADTRP PRCP PRKD1 CTSH MAP4K4 ATP2B4 | 3.32e-04 | 432 | 175 | 12 | GO:0010631 |
| GeneOntologyBiologicalProcess | hormone transport | TRPC1 ANXA7 RBP4 PFKL PFKM SLCO1B1 LEPR SIDT2 TRPV4 PRKD1 MAP4K4 SMAD2 | 3.32e-04 | 432 | 175 | 12 | GO:0009914 |
| GeneOntologyBiologicalProcess | epithelium migration | CLASP1 PSG1 PSG3 PSG5 PSG6 ITGA3 ADTRP PRCP PRKD1 CTSH MAP4K4 ATP2B4 | 3.54e-04 | 435 | 175 | 12 | GO:0090132 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.61e-04 | 40 | 175 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 3.67e-04 | 72 | 175 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | ERBB3 DSCAM PSG1 PSG3 PSG5 PSG6 ADTRP BTN2A2 TRPV4 MAP4K4 MUC4 | 3.73e-04 | 375 | 175 | 11 | GO:0007162 |
| GeneOntologyCellularComponent | basal part of cell | ERBB3 CLASP1 PSG1 PSG3 PSG5 PSG6 TRPC1 SLCO1B3 CLDN4 ITGA3 SLCO1B1 LEPR HEPH TJP1 PRCP ATP2B1 ATP2B2 ATP2B4 | 3.22e-09 | 378 | 175 | 18 | GO:0045178 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.62e-09 | 17 | 175 | 6 | GO:0001518 | |
| GeneOntologyCellularComponent | basal plasma membrane | ERBB3 PSG1 PSG3 PSG5 PSG6 TRPC1 SLCO1B3 CLDN4 ITGA3 SLCO1B1 LEPR HEPH TJP1 ATP2B1 ATP2B2 ATP2B4 | 5.20e-08 | 354 | 175 | 16 | GO:0009925 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ERBB3 PSG1 PSG3 PSG5 PSG6 TRPC1 SLCO1B3 ITGA3 SLCO1B1 LEPR HEPH TJP1 ATP2B1 ATP2B2 ATP2B4 | 8.62e-08 | 320 | 175 | 15 | GO:0016323 |
| GeneOntologyCellularComponent | sodium channel complex | 1.28e-07 | 29 | 175 | 6 | GO:0034706 | |
| GeneOntologyCellularComponent | apical plasma membrane | ERBB3 PSG1 PSG3 PSG5 PSG6 CLDN4 PFKM ITPK1 PLPP1 TJP1 SLC22A13 TRPV4 SLC2A13 MUC4 ATP2B1 ATP2B2 | 3.59e-06 | 487 | 175 | 16 | GO:0016324 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 7.98e-06 | 16 | 175 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | apical part of cell | ERBB3 PSG1 PSG3 PSG5 PSG6 CLDN4 PFKM ITPK1 PLPP1 TJP1 SLC22A13 TRPV4 SLC2A13 MUC4 ATP2B1 ATP2B2 PDZD2 | 1.05e-05 | 592 | 175 | 17 | GO:0045177 |
| GeneOntologyCellularComponent | cell projection membrane | PSG1 PSG3 PSG5 PSG6 SLC28A3 ITGA3 EHD3 APPL2 EHD1 TRPV4 MUC4 ATP2B1 ATP2B2 | 7.28e-05 | 431 | 175 | 13 | GO:0031253 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.10e-04 | 90 | 175 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | presynaptic membrane | CACNA1A SCN11A ITGA3 ZDHHC17 SCN1A SCN2A SCN10A ATP2B1 ATP2B2 ATP2B4 | 1.19e-04 | 277 | 175 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1A SCN11A ERBB3 LRRTM1 ITGA3 ZDHHC17 CBLN1 SCN1A SCN2A SCN10A SORCS3 ATP2B1 ATP2B2 ATP2B4 KCNT1 | 1.21e-04 | 583 | 175 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | ciliary membrane | 1.76e-04 | 98 | 175 | 6 | GO:0060170 | |
| GeneOntologyCellularComponent | cilium | CFAP300 PSG1 PSG3 PSG5 PSG6 OXCT2 PFKM DNAH7 EHD3 WDR19 ARL6 CSNK1D EHD1 TRPV4 TUBD1 CTSH KIF17 ATP2B2 ATP2B4 | 1.97e-04 | 898 | 175 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | ciliary pocket membrane | 2.08e-04 | 3 | 175 | 2 | GO:0020018 | |
| GeneOntologyCellularComponent | ciliary pocket | 2.08e-04 | 3 | 175 | 2 | GO:0020016 | |
| GeneOntologyCellularComponent | 6-phosphofructokinase complex | 2.08e-04 | 3 | 175 | 2 | GO:0005945 | |
| GeneOntologyCellularComponent | C-fiber | 4.14e-04 | 4 | 175 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 5.00e-04 | 78 | 175 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | cation channel complex | 8.41e-04 | 235 | 175 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1A SCN11A ERBB3 PSG1 PSG3 PSG5 PSG6 ABCB6 ITGA3 TLR6 SCN1A SCN2A SCN3A SCN10A CACNA1I APBB1IP | 9.49e-04 | 785 | 175 | 16 | GO:0098797 |
| GeneOntologyCellularComponent | microtubule | CLASP1 KIF21A HSPH1 KIF12 DYSF DNAH7 ARL6 CSNK1D TRPV4 TUBD1 KIF17 CNP | 1.83e-03 | 533 | 175 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 2.11e-03 | 335 | 175 | 9 | GO:0061695 | |
| MousePheno | decreased palatine bone horizontal plate size | 1.82e-06 | 10 | 138 | 4 | MP:0009895 | |
| MousePheno | abnormal vascular wound healing | 7.43e-06 | 73 | 138 | 7 | MP:0004883 | |
| MousePheno | decreased carbon dioxide production | 1.21e-05 | 31 | 138 | 5 | MP:0008964 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.96e-05 | 17 | 138 | 4 | MP:0031047 | |
| MousePheno | abnormal pancreatic beta cell physiology | 2.44e-05 | 196 | 138 | 10 | MP:0003562 | |
| MousePheno | small presphenoid bone | 2.50e-05 | 18 | 138 | 4 | MP:0030383 | |
| MousePheno | abnormal endocrine pancreas physiology | 3.16e-05 | 202 | 138 | 10 | MP:0010147 | |
| MousePheno | decreased fibroblast cell migration | 3.83e-05 | 39 | 138 | 5 | MP:0011708 | |
| MousePheno | increased insulin secretion | 3.89e-05 | 64 | 138 | 6 | MP:0003058 | |
| MousePheno | increased skeletal muscle triglyceride level | 4.78e-05 | 21 | 138 | 4 | MP:0031415 | |
| MousePheno | abnormal insulin secretion | 4.94e-05 | 171 | 138 | 9 | MP:0003564 | |
| MousePheno | abnormal action potential | 5.12e-05 | 133 | 138 | 8 | MP:0005402 | |
| MousePheno | abnormal endocrine pancreas secretion | 6.18e-05 | 176 | 138 | 9 | MP:0014195 | |
| MousePheno | abnormal Purkinje cell innervation | 7.57e-05 | 9 | 138 | 3 | MP:0003894 | |
| MousePheno | decreased fatty acid oxidation | 8.29e-05 | 24 | 138 | 4 | MP:0014172 | |
| MousePheno | abnormal pancreas secretion | 8.35e-05 | 183 | 138 | 9 | MP:0002694 | |
| MousePheno | abnormal fibroblast migration | 1.06e-04 | 48 | 138 | 5 | MP:0011706 | |
| MousePheno | abnormal frontal bone morphology | 1.11e-04 | 77 | 138 | 6 | MP:0000107 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.17e-04 | 49 | 138 | 5 | MP:0020948 | |
| MousePheno | increased abdominal fat pad weight | 1.34e-04 | 27 | 138 | 4 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 1.55e-04 | 28 | 138 | 4 | MP:0020950 | |
| MousePheno | abnormal palatine bone horizontal plate morphology | 1.55e-04 | 28 | 138 | 4 | MP:0004537 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 2.33e-04 | 31 | 138 | 4 | MP:0031413 | |
| MousePheno | asymmetric sternocostal joints | 2.33e-04 | 31 | 138 | 4 | MP:0008146 | |
| MousePheno | impaired ability to fire action potentials | 2.50e-04 | 13 | 138 | 3 | MP:0002578 | |
| MousePheno | short premaxilla | 2.50e-04 | 13 | 138 | 3 | MP:0000091 | |
| MousePheno | abnormal endocrine gland physiology | PSG1 PSG3 PSG5 PSG6 VPS13C POLG ANXA7 PFKM LEPR TIPARP SIDT2 PDZD2 | 2.53e-04 | 363 | 138 | 12 | MP:0013561 |
| MousePheno | abnormal channel response | 2.98e-04 | 33 | 138 | 4 | MP:0003484 | |
| MousePheno | abnormal presphenoid bone morphology | 2.98e-04 | 33 | 138 | 4 | MP:0004448 | |
| MousePheno | abnormal single cell response | 3.75e-04 | 35 | 138 | 4 | MP:0003463 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 3.75e-04 | 35 | 138 | 4 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 4.19e-04 | 36 | 138 | 4 | MP:0031412 | |
| MousePheno | abnormal mechanical nociception | 4.19e-04 | 36 | 138 | 4 | MP:0002734 | |
| MousePheno | decreased cell migration | 4.48e-04 | 65 | 138 | 5 | MP:0011805 | |
| MousePheno | abnormal carbon dioxide production | 5.15e-04 | 67 | 138 | 5 | MP:0008962 | |
| MousePheno | asymmetric rib joints | 5.72e-04 | 39 | 138 | 4 | MP:0000155 | |
| MousePheno | abnormal premaxilla morphology | 5.72e-04 | 39 | 138 | 4 | MP:0002820 | |
| MousePheno | decreased muscle cell glucose uptake | 5.72e-04 | 39 | 138 | 4 | MP:0030022 | |
| MousePheno | increased vertical stereotypic behavior | 5.73e-04 | 4 | 138 | 2 | MP:0009849 | |
| MousePheno | abnormal pancreas physiology | 6.38e-04 | 292 | 138 | 10 | MP:0002693 | |
| MousePheno | abnormal wound healing | 6.57e-04 | 193 | 138 | 8 | MP:0005023 | |
| Domain | Na_channel_asu | 1.47e-08 | 10 | 171 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 1.47e-08 | 10 | 171 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 1.47e-08 | 10 | 171 | 5 | PF06512 | |
| Domain | Channel_four-helix_dom | 8.58e-07 | 57 | 171 | 7 | IPR027359 | |
| Domain | - | 8.58e-07 | 57 | 171 | 7 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 1.04e-06 | 114 | 171 | 9 | IPR005821 | |
| Domain | Ion_trans | 1.04e-06 | 114 | 171 | 9 | PF00520 | |
| Domain | ATP_Ca_trans_C | 3.00e-06 | 4 | 171 | 3 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 3.00e-06 | 4 | 171 | 3 | PF12424 | |
| Domain | P-type_ATPase_IIB | 3.00e-06 | 4 | 171 | 3 | IPR006408 | |
| Domain | Na_trans_cytopl | 1.48e-05 | 6 | 171 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 1.48e-05 | 6 | 171 | 3 | IPR024583 | |
| Domain | ATP2B1/4 | 8.33e-05 | 2 | 171 | 2 | IPR030319 | |
| Domain | EHD1/EHD3 | 8.33e-05 | 2 | 171 | 2 | IPR029951 | |
| Domain | IQ_motif_EF-hand-BS | 1.78e-04 | 90 | 171 | 6 | IPR000048 | |
| Domain | IQ | 2.13e-04 | 93 | 171 | 6 | PS50096 | |
| Domain | 6-Pfructokinase_euk | 2.49e-04 | 3 | 171 | 2 | IPR009161 | |
| Domain | PHOSPHOFRUCTOKINASE | 2.49e-04 | 3 | 171 | 2 | PS00433 | |
| Domain | Phosphofructokinase_CS | 2.49e-04 | 3 | 171 | 2 | IPR015912 | |
| Domain | PFK | 2.49e-04 | 3 | 171 | 2 | PF00365 | |
| Domain | ATP_PFK | 2.49e-04 | 3 | 171 | 2 | IPR022953 | |
| Domain | Phosphofructokinase_dom | 2.49e-04 | 3 | 171 | 2 | IPR000023 | |
| Domain | Dynamin_GTPase | 3.16e-04 | 15 | 171 | 3 | IPR001401 | |
| Domain | Dynamin_SF | 3.16e-04 | 15 | 171 | 3 | IPR022812 | |
| Domain | Dynamin_N | 3.16e-04 | 15 | 171 | 3 | PF00350 | |
| Domain | ATPase_P-typ_TM_dom | 3.87e-04 | 16 | 171 | 3 | IPR023298 | |
| Domain | - | 3.87e-04 | 16 | 171 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.67e-04 | 17 | 171 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.67e-04 | 17 | 171 | 3 | PF00689 | |
| Domain | BK_channel_a | 4.94e-04 | 4 | 171 | 2 | PF03493 | |
| Domain | K_chnl_Ca-activ_BK_asu | 4.94e-04 | 4 | 171 | 2 | IPR003929 | |
| Domain | Cation_ATPase_N | 5.56e-04 | 18 | 171 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 5.56e-04 | 18 | 171 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 6.56e-04 | 19 | 171 | 3 | IPR004014 | |
| Domain | HAD-like_dom | 7.92e-04 | 79 | 171 | 5 | IPR023214 | |
| Domain | EHD_N | 8.18e-04 | 5 | 171 | 2 | IPR031692 | |
| Domain | EHD_N | 8.18e-04 | 5 | 171 | 2 | PF16880 | |
| Domain | IQ | 8.87e-04 | 81 | 171 | 5 | SM00015 | |
| Pathway | REACTOME_HEMOSTASIS | DOCK2 PSG1 SPP2 PSG3 PSG5 PSG6 KIF21A KIF12 ITGA3 ITPK1 EHD3 SERPINB8 PRCP EHD1 CHID1 ATP2B1 ATP2B2 ATP2B4 APBB1IP | 1.04e-06 | 571 | 129 | 19 | MM14472 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | SCN11A TRPC1 DYSF SCN1A SCN2A SCN3A SCN10A CACNA1I ATP2B1 ATP2B2 ATP2B4 | 2.55e-06 | 203 | 129 | 11 | M5485 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.95e-06 | 130 | 129 | 9 | M27454 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 8.33e-06 | 31 | 129 | 5 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 9.80e-06 | 32 | 129 | 5 | M27455 | |
| Pathway | REACTOME_HEMOSTASIS | DOCK2 PSG1 SPP2 PSG3 PSG5 PSG6 KIF21A KIF12 ITGA3 ITPK1 EHD3 SERPINB8 PRCP EHD1 CHID1 ATP2B1 ATP2B2 ATP2B4 APBB1IP | 1.29e-05 | 679 | 129 | 19 | M8395 |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 5.71e-05 | 188 | 129 | 9 | MM15828 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.55e-04 | 12 | 129 | 3 | M27326 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.30e-04 | 178 | 129 | 8 | M2890 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.53e-04 | 14 | 129 | 3 | MM15052 | |
| Pathway | WP_KENNEDY_PATHWAY | 2.53e-04 | 14 | 129 | 3 | MM15980 | |
| Pathway | WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS | 2.53e-04 | 14 | 129 | 3 | M39620 | |
| Pubmed | 4.00e-10 | 9 | 177 | 5 | 16382098 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | EPHX2 SCN11A VPS13C PSMA2 AHCTF1 ANXA7 RBP4 KIF12 ABCB6 PFKL ITGA3 DYSF ARL6 CRYL1 CRYZ APPL2 PLPP1 PRCP SLC22A13 EHD1 SCN10A CNP MITD1 | 2.46e-09 | 1016 | 177 | 23 | 19056867 |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 9.65e-09 | 6 | 177 | 4 | 23652591 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CLASP1 RTCB PSMA2 SMCHD1 TM9SF3 POLRMT PSMD8 PFKM PRPF8 LRIG2 TJP1 LNPEP CSNK1D PPP4R2 XRN1 CDC5L HECTD1 ATP2B1 CNP SMAD2 PPP6R3 | 2.96e-08 | 974 | 177 | 21 | 28675297 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.85e-08 | 38 | 177 | 6 | 30786075 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 23859570 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 12610651 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 18784617 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 17544618 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 14973256 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | RNMT CLASP1 SMCHD1 AHCTF1 KIF21A APEX1 PRPF8 APPL2 TJP1 SGPL1 RAB3GAP2 XRN1 CNP PPP6R3 | 3.04e-07 | 498 | 177 | 14 | 36634849 |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 4.47e-07 | 13 | 177 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 4.47e-07 | 13 | 177 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 4.47e-07 | 13 | 177 | 4 | 16638824 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 20044046 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 32150576 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 6265583 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 4.47e-07 | 13 | 177 | 4 | 12832451 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 4.47e-07 | 13 | 177 | 4 | 21670291 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 22162753 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 2702644 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 8380065 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 1279194 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 25724769 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 4.47e-07 | 13 | 177 | 4 | 22092845 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 11801635 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 4.47e-07 | 13 | 177 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 4.47e-07 | 13 | 177 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 4.47e-07 | 13 | 177 | 4 | 23800882 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 19285068 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 21760897 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 4.47e-07 | 13 | 177 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 4.47e-07 | 13 | 177 | 4 | 39168268 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 8402684 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 16619040 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 4.47e-07 | 13 | 177 | 4 | 8209741 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 4.47e-07 | 13 | 177 | 4 | 21949477 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 26219866 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 2133556 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 32521208 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 19406938 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 4.47e-07 | 13 | 177 | 4 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 4.47e-07 | 13 | 177 | 4 | 19358828 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 16680193 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 4.47e-07 | 13 | 177 | 4 | 34058224 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 10964771 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 32169849 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 4.47e-07 | 13 | 177 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 4.47e-07 | 13 | 177 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 4.47e-07 | 13 | 177 | 4 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 4.47e-07 | 13 | 177 | 4 | 23935487 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 15331748 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 4.47e-07 | 13 | 177 | 4 | 22406619 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 4.47e-07 | 13 | 177 | 4 | 25972571 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 19008452 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 4.47e-07 | 13 | 177 | 4 | 15220458 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 18843289 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 15207636 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 21081647 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 11133662 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 11483763 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 2164599 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 15123669 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 29396368 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 18003729 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 4.47e-07 | 13 | 177 | 4 | 33352461 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 38381498 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 20739537 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 4.47e-07 | 13 | 177 | 4 | 27695943 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 20404914 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 4.47e-07 | 13 | 177 | 4 | 32027621 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 4.47e-07 | 13 | 177 | 4 | 27777319 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 18848945 | ||
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 5.16e-07 | 4 | 177 | 3 | 12209837 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 17537961 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 12784250 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 5.16e-07 | 4 | 177 | 3 | 8245032 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 5.16e-07 | 4 | 177 | 3 | 7989379 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 5.16e-07 | 4 | 177 | 3 | 11152753 | |
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 5.16e-07 | 4 | 177 | 3 | 39024979 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 5.16e-07 | 4 | 177 | 3 | 36130203 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 35801810 | ||
| Interaction | RXFP1 interactions | 1.12e-06 | 90 | 174 | 8 | int:RXFP1 | |
| Interaction | SCN10A interactions | 1.69e-06 | 11 | 174 | 4 | int:SCN10A | |
| Interaction | SCN11A interactions | 6.80e-06 | 15 | 174 | 4 | int:SCN11A | |
| Interaction | SNCA interactions | RNMT CLASP1 VPS13C SMCHD1 AHCTF1 KIF21A HSPH1 APEX1 PRPF8 TIPARP USP8 APPL2 TJP1 CSNK1D SGPL1 RAB3GAP2 XRN1 CNP PPP6R3 | 1.45e-05 | 716 | 174 | 19 | int:SNCA |
| Cytoband | 19q13.2 | 4.49e-05 | 164 | 177 | 6 | 19q13.2 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.08e-09 | 9 | 113 | 5 | 1203 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 4.62e-07 | 11 | 113 | 4 | 1315 | |
| GeneFamily | ATPases Ca2+ transporting | 1.94e-05 | 9 | 113 | 3 | 1209 | |
| GeneFamily | Potassium sodium-activated channel subfamily T | 3.87e-05 | 2 | 113 | 2 | 856 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 5.59e-04 | 163 | 113 | 6 | 590 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.97e-03 | 46 | 113 | 3 | 622 | |
| GeneFamily | Solute carriers | SLC25A46 SLCO1B3 SLC28A3 SLCO1B1 SLC11A1 SLC22A13 SLC16A14 SLC2A13 | 3.37e-03 | 395 | 113 | 8 | 752 |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 3.85e-03 | 15 | 113 | 2 | 458 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | RNMT RPS6KA5 PSG1 PSG6 HSPH1 TIPARP WDR19 LRIG2 BTN3A3 BTN2A2 PLPP1 TJP1 PHF3 SGPL1 WDFY3 ATP2B1 ATP2B4 HECA CUX1 PDZD2 | 6.74e-07 | 822 | 175 | 20 | M6782 |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 3.62e-06 | 135 | 175 | 8 | MM965 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | ERBB3 PSG1 PSG3 PSG5 PSG6 ANXA7 SLC28A3 CLDN4 MAP3K1 CHPT1 SULT2B1 VILL MPI | 8.02e-06 | 436 | 175 | 13 | MM1326 |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP | 8.47e-06 | 200 | 175 | 9 | M9380 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP | 8.47e-06 | 200 | 175 | 9 | M9886 | |
| Coexpression | SCHMAHL_PDGF_SIGNALING | 2.39e-05 | 9 | 175 | 3 | MM538 | |
| Coexpression | SCHMAHL_PDGF_SIGNALING | 3.39e-05 | 10 | 175 | 3 | M1285 | |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 5.42e-05 | 196 | 175 | 8 | M8135 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN | 5.42e-05 | 196 | 175 | 8 | M4973 | |
| Coexpression | GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 5.82e-05 | 198 | 175 | 8 | M7944 | |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_UP | 5.82e-05 | 198 | 175 | 8 | M3116 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 5.97e-05 | 32 | 175 | 4 | MM2 | |
| Coexpression | GSE17721_0.5H_VS_12H_CPG_BMDC_DN | 6.03e-05 | 199 | 175 | 8 | M4122 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 6.44e-05 | 102 | 175 | 6 | M10290 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 8.55e-05 | 35 | 175 | 4 | MM757 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1A DSCAM GALNT13 MAP3K1 KCNT2 SCN1A SCN2A SCN3A SORCS3 SLC2A13 PDZD2 | 5.21e-10 | 200 | 177 | 11 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1A DSCAM GALNT13 MAP3K1 KCNT2 SCN1A SCN2A SCN3A SORCS3 SLC2A13 PDZD2 | 5.21e-10 | 200 | 177 | 11 | cc3409518f8b436ea92deb955e81114b3f410ff7 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1A DSCAM GALNT13 MAP3K1 KCNT2 SCN1A SCN2A SCN3A SORCS3 SLC2A13 PDZD2 | 5.21e-10 | 200 | 177 | 11 | c24a3099e3d96d8b72f6d05286bb355d661a0377 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1A DSCAM GALNT13 MAP3K1 KCNT2 SCN1A SCN2A SCN3A SORCS3 SLC2A13 PDZD2 | 5.21e-10 | 200 | 177 | 11 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1A DSCAM GALNT13 MAP3K1 KCNT2 SCN1A SCN2A SCN3A SORCS3 SLC2A13 PDZD2 | 5.21e-10 | 200 | 177 | 11 | 310cd53db1c137f6af74e6ae682221d7ac27310c |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1A DSCAM GALNT13 MAP3K1 KCNT2 SCN1A SCN2A SCN3A SORCS3 SLC2A13 PDZD2 | 5.21e-10 | 200 | 177 | 11 | 961858738ce35db8760c8c2e136f8369bc444ccf |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.57e-08 | 196 | 177 | 9 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.57e-08 | 196 | 177 | 9 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.56e-07 | 172 | 177 | 8 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-06 | 193 | 177 | 8 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-06 | 193 | 177 | 8 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-06 | 194 | 177 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.17e-06 | 195 | 177 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.17e-06 | 195 | 177 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-06 | 198 | 177 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-06 | 200 | 177 | 8 | 401d50fa394fa863fa7836344110ae5c7af3250a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-06 | 200 | 177 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.19e-06 | 106 | 177 | 6 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.19e-06 | 106 | 177 | 6 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.19e-06 | 106 | 177 | 6 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-06 | 164 | 177 | 7 | 1592a5becad7e0f3f990f0d7581d75fcfc7da023 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 184 | 177 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-06 | 185 | 177 | 7 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-06 | 186 | 177 | 7 | 75258d88e23112fd1f0f7c71ef0366abb400d33e | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.01e-05 | 187 | 177 | 7 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.12e-05 | 190 | 177 | 7 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 190 | 177 | 7 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 193 | 177 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 193 | 177 | 7 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 193 | 177 | 7 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 194 | 177 | 7 | 74a9fdb73f279bebb6337510deab9aaaf9f7e957 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 195 | 177 | 7 | 25703e3c2e0512ef12e7aa389fad3968c3f13905 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-05 | 195 | 177 | 7 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 195 | 177 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-05 | 197 | 177 | 7 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.42e-05 | 197 | 177 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 198 | 177 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 198 | 177 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | NS-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.51e-05 | 199 | 177 | 7 | d64adb68502be596ce55fb2cb63fe1cfa2c5f8ba | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.51e-05 | 199 | 177 | 7 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.51e-05 | 199 | 177 | 7 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-05 | 199 | 177 | 7 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-05 | 199 | 177 | 7 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | NS-critical-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.51e-05 | 199 | 177 | 7 | 3b68197ec01c5f2b315d9e9b6eb02d5f6b5b77a3 | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.56e-05 | 200 | 177 | 7 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | NS-moderate-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.56e-05 | 200 | 177 | 7 | 85940b4bf7971b872469dea8b8d7a45bdeb2a909 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.56e-05 | 200 | 177 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.56e-05 | 200 | 177 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.66e-05 | 155 | 177 | 6 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-05 | 160 | 177 | 6 | 830e3ef8c9708d25872c3052a0b2682fa9372111 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.53e-05 | 161 | 177 | 6 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.42e-05 | 176 | 177 | 6 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-05 | 176 | 177 | 6 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 177 | 177 | 6 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 177 | 177 | 6 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | Children_(3_yrs)|World / Lineage, Cell type, age group and donor | 7.90e-05 | 178 | 177 | 6 | df2ecd3214590b914f2762db57efe780ba038db3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.66e-05 | 181 | 177 | 6 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.93e-05 | 182 | 177 | 6 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.20e-05 | 183 | 177 | 6 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 9.48e-05 | 184 | 177 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.01e-04 | 186 | 177 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.01e-04 | 186 | 177 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Pulmonary_NE_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 186 | 177 | 6 | dfd67d67c103c942de6c8acef8d81e57a9886154 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 187 | 177 | 6 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 187 | 177 | 6 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 187 | 177 | 6 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.07e-04 | 188 | 177 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-04 | 188 | 177 | 6 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-04 | 188 | 177 | 6 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.07e-04 | 188 | 177 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | wk_08-11-Epithelial-PNS-intermediate_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 188 | 177 | 6 | 3f3a744b2615bf72f6119f26087099110c0d21fc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 189 | 177 | 6 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 189 | 177 | 6 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 189 | 177 | 6 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 189 | 177 | 6 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 189 | 177 | 6 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 190 | 177 | 6 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 190 | 177 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-04 | 190 | 177 | 6 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 190 | 177 | 6 | a124e1c12af70161b9ead5d677afa660610444ee | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-04 | 191 | 177 | 6 | 30e7cc5f7eadf90ab0900a73fdfe48f9a1adcbfb | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-04 | 191 | 177 | 6 | 41d2f5278f6d5f52a5bdf4f3df70969481c00162 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 191 | 177 | 6 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 191 | 177 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 1.20e-04 | 192 | 177 | 6 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 192 | 177 | 6 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 192 | 177 | 6 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 192 | 177 | 6 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 192 | 177 | 6 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.20e-04 | 192 | 177 | 6 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 192 | 177 | 6 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 192 | 177 | 6 | ee9a23a4f00424a50bd7907cf3b12dc50027877e | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-Memory_B_cells|GI_large-bowel / Manually curated celltypes from each tissue | 1.20e-04 | 192 | 177 | 6 | 31f7245bce79969674a775ecf175e7c6af68b503 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 193 | 177 | 6 | 21c397912f2dd1f4115cddbdc01a6a9beb1332cc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 193 | 177 | 6 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 193 | 177 | 6 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 193 | 177 | 6 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 194 | 177 | 6 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 194 | 177 | 6 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-04 | 194 | 177 | 6 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| Drug | Zonisamide | 1.41e-07 | 17 | 174 | 5 | DB00909 | |
| Drug | pP-8 | 6.68e-07 | 10 | 174 | 4 | CID000444681 | |
| Drug | agelasine B | 1.33e-06 | 46 | 174 | 6 | CID006439899 | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | EPHX2 PFKL DYSF SLC11A1 PHF3 RAB3GAP2 SCN10A TRPV4 CACNA1I ATP2B4 | 2.95e-06 | 197 | 174 | 10 | 5563_UP |
| Drug | AC1Q6S1N | 7.35e-06 | 93 | 174 | 7 | CID000000290 | |
| Drug | 5,6-DiHETrE | 8.63e-06 | 6 | 174 | 3 | CID005283142 | |
| Drug | APETx1, Anthopleura elegantissima | 8.63e-06 | 6 | 174 | 3 | ctd:C475726 | |
| Drug | fenpropathrin | 8.63e-06 | 6 | 174 | 3 | ctd:C044267 | |
| Drug | lanthanum | 1.02e-05 | 136 | 174 | 8 | CID000023926 | |
| Drug | saxitoxin | 1.04e-05 | 65 | 174 | 6 | CID000037165 | |
| Drug | MgCl2 | PSMA2 POLG OXCT2 APEX1 PFKM PLPP1 ENTPD3 MYO18B TUBD1 ATP2B1 ATP2B2 ATP2B4 | 1.90e-05 | 354 | 174 | 12 | CID000024584 |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 2.39e-05 | 8 | 174 | 3 | ctd:C489827 | |
| Drug | Mesalamine [89-57-6]; Up 200; 26.2uM; HL60; HT_HG-U133A | 2.44e-05 | 200 | 174 | 9 | 6162_UP | |
| Drug | AC1L25Y6 | 2.60e-05 | 23 | 174 | 4 | CID000015465 | |
| Drug | C13932 | 3.08e-05 | 206 | 174 | 9 | CID000168297 | |
| Drug | AC1L1G0K | 3.57e-05 | 49 | 174 | 5 | CID000003473 | |
| Drug | dodecyl ether | 4.32e-05 | 26 | 174 | 4 | CID000020667 | |
| Drug | 1sqc | 5.06e-05 | 10 | 174 | 3 | CID000444279 | |
| Drug | Vanadium | 5.74e-05 | 173 | 174 | 8 | ctd:D014639 | |
| Drug | benz(a)anthracene-5,6-imine | 5.81e-05 | 2 | 174 | 2 | CID000051305 | |
| Drug | AC1L26S0 | 5.81e-05 | 2 | 174 | 2 | CID000015863 | |
| Drug | 2,3,5-tri-O-benzyl-D-arabinofuranose | 5.81e-05 | 2 | 174 | 2 | CID000255457 | |
| Drug | caloxin 1b1 | 5.81e-05 | 2 | 174 | 2 | ctd:C510327 | |
| Drug | ethylphenylepoxygeranyl ether | 5.81e-05 | 2 | 174 | 2 | ctd:C100167 | |
| Drug | (5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid | 5.81e-05 | 2 | 174 | 2 | ctd:C561635 | |
| Drug | 1-methylcyclohexene oxide | 5.81e-05 | 2 | 174 | 2 | CID000224243 | |
| Drug | Cyclodecene (z) | 5.81e-05 | 2 | 174 | 2 | CID000013633 | |
| Drug | benz(a)anthracene-5,6-oxide | 5.81e-05 | 2 | 174 | 2 | CID000182424 | |
| Drug | desyl chloride | 5.81e-05 | 2 | 174 | 2 | CID000095343 | |
| Drug | 9,12,13-Todea | 5.81e-05 | 2 | 174 | 2 | CID005282966 | |
| Drug | 3-methylcholanthrene-11,12-oxide | 5.81e-05 | 2 | 174 | 2 | CID000105086 | |
| Drug | 2,5-dimethylquinone | 6.92e-05 | 11 | 174 | 3 | CID000008718 | |
| Drug | p-methylstyrene | 9.17e-05 | 12 | 174 | 3 | CID000012161 | |
| Drug | 1vyq | 9.17e-05 | 12 | 174 | 3 | CID004369390 | |
| Drug | Ro 46861 | 9.17e-05 | 12 | 174 | 3 | CID000003128 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 9.89e-05 | 187 | 174 | 8 | 6995_UP | |
| Drug | fenvalerate | 1.02e-04 | 97 | 174 | 6 | ctd:C017690 | |
| Drug | verapamil | CACNA1A RBP4 ABCB6 SLCO1B1 KCNT2 SCN3A SCN10A CACNA1I PRKD1 ATP2B1 ATP2B2 ATP2B4 MPI | 1.06e-04 | 490 | 174 | 13 | CID000002520 |
| Drug | acetyl phosphate | 1.08e-04 | 98 | 174 | 6 | CID000000186 | |
| Drug | sodium | TRPC1 SLCO1B3 SLC28A3 CLDN4 PRPF8 SLCO1B1 CRYZ SLC11A1 KCNT2 SULT2B1 TJP1 SCN2A SCN3A SCN10A PRKD1 SLC2A13 ATP2B1 ATP2B2 ATP2B4 | 1.17e-04 | 944 | 174 | 19 | CID000000923 |
| Drug | NSC406942 | RTCB POLG HSPH1 APEX1 PFKM TJP1 CSNK1D PISD M6PR ATP2B1 ATP2B2 ATP2B4 CNP MPI | 1.18e-04 | 565 | 174 | 14 | CID000001115 |
| Drug | 8-hydroxycoumarin | 1.19e-04 | 13 | 174 | 3 | CID000122783 | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.19e-04 | 192 | 174 | 8 | 2919_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.23e-04 | 193 | 174 | 8 | 2721_DN | |
| Drug | manganese | CACNA1A POLG POLRMT APEX1 XPNPEP1 ITGA3 ITPK1 PHKA2 SLC11A1 PRCP CSNK1D CACNA1I TUBD1 M6PR ATP2B1 ATP2B2 ATP2B4 | 1.25e-04 | 791 | 174 | 17 | CID000023930 |
| Drug | Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 174 | 8 | 2828_UP | |
| Drug | p-nitrophenyl phosphate | 1.28e-04 | 194 | 174 | 8 | CID000000378 | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 174 | 8 | 3885_UP | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A | 1.32e-04 | 195 | 174 | 8 | 1184_UP | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 6101_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 174 | 8 | 2229_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 1506_UP | |
| Drug | dexamethasone; Up 200; 1uM; MCF7; HG-U133A | 1.42e-04 | 197 | 174 | 8 | 255_UP | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 10uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 174 | 8 | 4559_UP | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.47e-04 | 198 | 174 | 8 | 2455_DN | |
| Drug | Didemnins | 1.50e-04 | 14 | 174 | 3 | CID000123844 | |
| Drug | p-hydroxyhippuric acid | 1.50e-04 | 14 | 174 | 3 | CID000151012 | |
| Drug | AC1L1IHP | RPS6KA5 PSMA2 KIF21A OXCT2 KIF12 PSMD8 MAP3K1 PHKA2 CSNK1D PRKD1 TUBD1 KIF17 M6PR THAP12 PPP6R3 MPI | 1.54e-04 | 728 | 174 | 16 | CID000004584 |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.57e-04 | 200 | 174 | 8 | 5570_UP | |
| Drug | isopropamide | 1.73e-04 | 3 | 174 | 2 | CID000003775 | |
| Drug | Cinnamylbenzene | 1.73e-04 | 3 | 174 | 2 | CID000099034 | |
| Drug | tridiphane | 1.73e-04 | 3 | 174 | 2 | ctd:C051460 | |
| Drug | 5,6-epoxy-8,11,14-eicosatrienoic acid | 1.73e-04 | 3 | 174 | 2 | ctd:C040776 | |
| Drug | AC1L977H | 1.73e-04 | 3 | 174 | 2 | CID000439366 | |
| Drug | allyl glycidyl ether | 1.73e-04 | 3 | 174 | 2 | CID000007838 | |
| Drug | indene oxide | 1.73e-04 | 3 | 174 | 2 | CID000092838 | |
| Drug | 5,6-dihydroxyprostaglandin E1 | 1.73e-04 | 3 | 174 | 2 | CID006444125 | |
| Drug | 8-p-menthene-1,2-diol | 1.73e-04 | 3 | 174 | 2 | CID000094217 | |
| Drug | C14835 | 1.73e-04 | 3 | 174 | 2 | CID005282965 | |
| Drug | AC1L3ZI5 | 1.73e-04 | 3 | 174 | 2 | CID000097902 | |
| Drug | epoxycyclododecane | 1.73e-04 | 3 | 174 | 2 | CID000009248 | |
| Drug | strontium | 1.74e-04 | 68 | 174 | 5 | CID000104798 | |
| Drug | 5-methylcytidine | 1.79e-04 | 37 | 174 | 4 | CID000092918 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.47e-09 | 10 | 170 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.47e-09 | 10 | 170 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 4.59e-09 | 12 | 170 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | CACNA1A SCN11A ITGA3 KCNT2 SCN1A SCN2A SCN3A SCN10A MAP4K4 KCNT1 | 3.98e-08 | 163 | 170 | 10 | DOID:1826 (implicated_via_orthology) |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.98e-06 | 152 | 170 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 3.71e-06 | 6 | 170 | 3 | DOID:0050429 (implicated_via_orthology) | |
| Disease | physical activity measurement | 1.34e-05 | 245 | 170 | 9 | EFO_0008002 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC | 3.30e-05 | 2 | 170 | 2 | C4016905 | |
| Disease | Rotor Syndrome | 3.30e-05 | 2 | 170 | 2 | C0220991 | |
| Disease | Rotor syndrome | 3.30e-05 | 2 | 170 | 2 | cv:C0220991 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE | 3.30e-05 | 2 | 170 | 2 | 237450 | |
| Disease | Primary Erythermalgia | 9.86e-05 | 3 | 170 | 2 | C0014805 | |
| Disease | Familial or sporadic hemiplegic migraine | 9.86e-05 | 3 | 170 | 2 | cv:CN295307 | |
| Disease | Familial hemiplegic migraine | 9.86e-05 | 3 | 170 | 2 | cv:C0338484 | |
| Disease | Epilepsies, Partial | 9.86e-05 | 3 | 170 | 2 | C0014547 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 9.86e-05 | 3 | 170 | 2 | C1833661 | |
| Disease | Tinnitus | 1.11e-04 | 130 | 170 | 6 | HP_0000360 | |
| Disease | reticulocyte measurement | CLASP1 PSG1 ASH1L ABCB6 PFKM PRPF8 SLCO1B1 MAP3K1 EHD3 TRMU PACS1 SGPL1 ATP2B1 ATP2B4 CUX1 APBB1IP PDZD2 | 1.32e-04 | 1053 | 170 | 17 | EFO_0010700 |
| Disease | cD177 antigen measurement | 1.44e-04 | 18 | 170 | 3 | EFO_0021866 | |
| Disease | Lung Neoplasms | 1.59e-04 | 265 | 170 | 8 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.64e-04 | 266 | 170 | 8 | C0242379 | |
| Disease | glycogen storage disease (implicated_via_orthology) | 1.96e-04 | 4 | 170 | 2 | DOID:2747 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 2.07e-04 | 93 | 170 | 5 | C1535926 | |
| Disease | migraine disorder | 2.40e-04 | 357 | 170 | 9 | MONDO_0005277 | |
| Disease | Prostatic Neoplasms | TBXAS1 EPHX1 ERBB3 ASH1L APEX1 TLR6 MAP3K1 CRYL1 APPL2 SULT2B1 MUC4 M6PR | 2.53e-04 | 616 | 170 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | TBXAS1 EPHX1 ERBB3 ASH1L APEX1 TLR6 MAP3K1 CRYL1 APPL2 SULT2B1 MUC4 M6PR | 2.53e-04 | 616 | 170 | 12 | C0376358 |
| Disease | anxiety disorder (implicated_via_orthology) | 2.67e-04 | 22 | 170 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | ovarian cancer (is_implicated_in) | 3.09e-04 | 56 | 170 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 3.26e-04 | 5 | 170 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | free androgen index | 3.38e-04 | 374 | 170 | 9 | EFO_0007005 | |
| Disease | reticulocyte count | CLASP1 PSG1 ASH1L ABCB6 PFKM PRPF8 SLCO1B1 MAP3K1 EHD3 DCUN1D1 SGPL1 ATP2B1 ATP2B4 CUX1 APBB1IP PDZD2 | 3.76e-04 | 1045 | 170 | 16 | EFO_0007986 |
| Disease | Epilepsy | 4.31e-04 | 109 | 170 | 5 | C0014544 | |
| Disease | bilirubin metabolic disorder (is_implicated_in) | 4.88e-04 | 6 | 170 | 2 | DOID:2741 (is_implicated_in) | |
| Disease | retinal disease (implicated_via_orthology) | 4.88e-04 | 6 | 170 | 2 | DOID:5679 (implicated_via_orthology) | |
| Disease | Glycogen Storage Disease | 4.96e-04 | 27 | 170 | 3 | C0017919 | |
| Disease | blood phosphate measurement | 5.33e-04 | 174 | 170 | 6 | EFO_0010972 | |
| Disease | susceptibility to cold sores measurement | 5.48e-04 | 65 | 170 | 4 | EFO_0008402 | |
| Disease | bipolar disorder | DOCK2 IQCH CLASP1 XPNPEP1 PACS1 SCN2A PRKD1 IMMP2L CTSH ATP2B2 ATP2B4 | 5.48e-04 | 577 | 170 | 11 | MONDO_0004985 |
| Disease | Drug habituation | 5.51e-04 | 115 | 170 | 5 | C0013170 | |
| Disease | Drug abuse | 5.51e-04 | 115 | 170 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 5.51e-04 | 115 | 170 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 5.51e-04 | 115 | 170 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 5.51e-04 | 115 | 170 | 5 | C0013222 | |
| Disease | Drug Dependence | 5.51e-04 | 115 | 170 | 5 | C1510472 | |
| Disease | Substance Dependence | 5.51e-04 | 115 | 170 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 5.51e-04 | 115 | 170 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 5.51e-04 | 115 | 170 | 5 | C0029231 | |
| Disease | Substance abuse problem | 5.73e-04 | 116 | 170 | 5 | C0740858 | |
| Disease | acute lymphoblastic leukemia | 5.80e-04 | 66 | 170 | 4 | EFO_0000220 | |
| Disease | lysophosphatidylethanolamine 20:4 measurement | 6.15e-04 | 29 | 170 | 3 | EFO_0010370 | |
| Disease | Seizure, Febrile, Simple | 6.80e-04 | 7 | 170 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 6.80e-04 | 7 | 170 | 2 | C0751057 | |
| Disease | hepatocyte growth factor receptor measurement | 6.80e-04 | 7 | 170 | 2 | EFO_0008153 | |
| Disease | Congenital Pain Insensitivity | 6.80e-04 | 7 | 170 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 6.80e-04 | 7 | 170 | 2 | C0020075 | |
| Disease | progressive supranuclear palsy | 7.50e-04 | 31 | 170 | 3 | MONDO_0019037 | |
| Disease | social communication impairment | 8.24e-04 | 32 | 170 | 3 | EFO_0005427 | |
| Disease | severe pre-eclampsia (is_marker_for) | 9.03e-04 | 8 | 170 | 2 | DOID:13129 (is_marker_for) | |
| Disease | Hereditary Motor and Sensory Neuropathy Type I | 9.03e-04 | 8 | 170 | 2 | C0751036 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 9.03e-04 | 8 | 170 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Roussy-Levy Syndrome (disorder) | 9.03e-04 | 8 | 170 | 2 | C0205713 | |
| Disease | deoxycholic acid glucuronide measurement | 9.03e-04 | 8 | 170 | 2 | EFO_0800575 | |
| Disease | phenol sulfate measurement | 9.03e-04 | 8 | 170 | 2 | EFO_0021011 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 9.03e-04 | 8 | 170 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Microphthalmia associated with colobomatous cyst | 9.03e-04 | 8 | 170 | 2 | C2931501 | |
| Disease | Charcot-Marie-Tooth Disease, Type Ib | 9.03e-04 | 8 | 170 | 2 | C0270912 | |
| Disease | Charcot-Marie-Tooth Disease, Type Ia (disorder) | 9.03e-04 | 8 | 170 | 2 | C0270911 | |
| Disease | Febrile Convulsions | 1.16e-03 | 9 | 170 | 2 | C0009952 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 1.16e-03 | 9 | 170 | 2 | EFO_0800562 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.16e-03 | 9 | 170 | 2 | C3502809 | |
| Disease | X-21467 measurement | 1.16e-03 | 9 | 170 | 2 | EFO_0020007 | |
| Disease | interleukin 16 measurement | 1.17e-03 | 36 | 170 | 3 | EFO_0008173 | |
| Disease | Cataract | 1.26e-03 | 37 | 170 | 3 | C0086543 | |
| Disease | bipolar I disorder | 1.38e-03 | 141 | 170 | 5 | EFO_0009963 | |
| Disease | nucleus accumbens volume change measurement | 1.75e-03 | 11 | 170 | 2 | EFO_0021493 | |
| Disease | oral microbiome measurement | 1.83e-03 | 42 | 170 | 3 | EFO_0801229 | |
| Disease | peptic esophagitis (biomarker_via_orthology) | 2.10e-03 | 12 | 170 | 2 | DOID:13976 (biomarker_via_orthology) | |
| Disease | Abruptio Placentae | 2.10e-03 | 12 | 170 | 2 | EFO_1001754 | |
| Disease | Charcot-Marie-Tooth Disease | 2.10e-03 | 12 | 170 | 2 | C0007959 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 2.47e-03 | 13 | 170 | 2 | C0751122 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 2.47e-03 | 13 | 170 | 2 | EFO_0800474 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 2.47e-03 | 13 | 170 | 2 | C0270914 | |
| Disease | pancreatic cancer (is_marker_for) | 2.81e-03 | 101 | 170 | 4 | DOID:1793 (is_marker_for) | |
| Disease | cholestasis (biomarker_via_orthology) | 2.85e-03 | 49 | 170 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | autism spectrum disorder, schizophrenia | 2.97e-03 | 327 | 170 | 7 | EFO_0003756, MONDO_0005090 | |
| Disease | HIV Infections | 3.02e-03 | 103 | 170 | 4 | C0019693 | |
| Disease | HIV Coinfection | 3.02e-03 | 103 | 170 | 4 | C4505456 | |
| Disease | MMR-related febrile seizures | 3.30e-03 | 15 | 170 | 2 | EFO_0006519 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 3.30e-03 | 15 | 170 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | immunoglobulin lambda-like polypeptide 1 measurement | 3.76e-03 | 16 | 170 | 2 | EFO_0801688 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 3.76e-03 | 16 | 170 | 2 | C0393706 | |
| Disease | Hepatomegaly | 3.76e-03 | 54 | 170 | 3 | C0019209 | |
| Disease | ecosanoids measurement | 3.96e-03 | 55 | 170 | 3 | EFO_0020044 | |
| Disease | brain aneurysm | 4.21e-03 | 113 | 170 | 4 | EFO_0003870 | |
| Disease | Glycogen storage disease | 4.24e-03 | 17 | 170 | 2 | cv:C0017919 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 4.24e-03 | 17 | 170 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 4.75e-03 | 18 | 170 | 2 | HP_0002373 | |
| Disease | Tourette syndrome, schizophrenia | 4.75e-03 | 18 | 170 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | cortical surface area measurement | ANO4 CACNA1A ERBB3 PCNX3 PSG1 DYSF DNAH7 MAP3K1 TJP1 RAB3GAP2 XRN1 PRKD1 CDC5L MAP4K4 CUX1 PDZD2 | 4.93e-03 | 1345 | 170 | 16 | EFO_0010736 |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 5.29e-03 | 19 | 170 | 2 | EFO_0002609, GO_0031427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGSYLRNGWNVMDFV | 161 | O00555 | |
| LLNWGVQIAKGMYYL | 811 | P21860 | |
| SWIMKGFLDYILGNS | 371 | Q8NEM8 | |
| MQKWSVNGVYRIGLY | 2231 | Q9NR48 | |
| VLLGMYSVWFQAQIK | 181 | Q8N8Q1 | |
| AAVMKYGKNQWSRIA | 21 | Q99459 | |
| LMFSDGGRNWKQYRR | 111 | Q9BZ76 | |
| WRLLESMKAQYVAGN | 711 | Q9UJX5 | |
| YWTMGLTDGNKYRAL | 431 | O00478 | |
| GVFAYIIQENLWMKL | 296 | Q13939 | |
| TLNQWVMGIRIAKYG | 406 | Q7Z5R6 | |
| ILANGARWKYMTLLN | 36 | Q96IZ2 | |
| LLSRGGVYADMWQLQ | 811 | Q9NP58 | |
| TVFDMSGQGRYRNLW | 66 | Q9H0F7 | |
| YDAWSLRKAMQGAGT | 261 | P20073 | |
| MNARSKNVGWRLDYF | 271 | P27695 | |
| LKQTWNNFMELGYPL | 656 | Q32M45 | |
| EMAIAYWNLVLNGRF | 176 | Q96GG9 | |
| QFGYWKRSGKMIVVE | 831 | Q03468 | |
| AVMWGRNVYDSISKF | 841 | P20020 | |
| MWGRNVYDSISKFLQ | 866 | Q01814 | |
| MWGRNVYDSISKFLQ | 831 | P23634 | |
| GWITANYLMGNFLEK | 186 | O75355 | |
| QYAAALQAGMEIGWL | 281 | Q08257 | |
| QRWLFKMDSEFRGNG | 651 | Q86VS3 | |
| MAQSQGWVKRYIKAF | 1 | Q96T52 | |
| MRMKYGGQEFWADLN | 301 | Q7Z3E1 | |
| GYKIMGLNNVTSQSW | 501 | Q9H2M9 | |
| NLRYEENMWPGSRKF | 13801 | Q8WXI7 | |
| ESWIRKMTNNGGYKA | 4431 | Q99102 | |
| RAIGMADLTKGYLQW | 691 | Q9BQK8 | |
| AYIRSNQTMGWGEKA | 1166 | O95819 | |
| QYSMWGNKFGVLLFL | 171 | Q9H8M7 | |
| YLEMRKGGLRNQWLQ | 86 | Q6ZST4 | |
| RNKGYNRSLDMWSVG | 756 | Q15139 | |
| MQTFLKGKRVGYWLS | 1 | Q13572 | |
| QNMWTKKGYDLAFRF | 161 | Q9UBI9 | |
| RRGYQVTGVFMKNWD | 26 | O75648 | |
| RAGQFTGLMQLTWLY | 81 | Q86UE6 | |
| YKTGNMDQALSLWFL | 61 | Q6ZP29 | |
| VAWAQRNLYGMLQEF | 411 | Q96FN5 | |
| NLVWQLGKDLLNMYI | 601 | Q92598 | |
| VYLWMERQKSGGNYS | 331 | Q5JUK3 | |
| REMNWLDYFALGGNK | 66 | Q53HL2 | |
| GSMFQYWKRFDLQQL | 6 | Q13948 | |
| RGAAQVMWFEKLYAG | 1126 | Q9H6A9 | |
| GAYNWKGNSYMIQRK | 216 | P26006 | |
| LLQVKYGGWQNVSMA | 161 | Q6UWM7 | |
| DLSVGGKNMFWYQQK | 46 | A0A075B6I3 | |
| WNGGFIYLIMLRRFK | 166 | O15018 | |
| DRNYGTKLGVKAMLW | 671 | P17858 | |
| LKLRGRSFMNNWEVY | 371 | P08237 | |
| DDLKNMWFGLYSRGN | 261 | P21128 | |
| YVFDWNMLKFGASRA | 286 | P48730 | |
| LWRMYLNFLVSLGNK | 1091 | Q9H7Z3 | |
| KAQQMYAATKGLRWY | 981 | P54098 | |
| MKNWIRDFYDSAGKQ | 481 | P42785 | |
| LYWLMKSSLNGDNFR | 906 | Q9UIQ6 | |
| QIRYGLSGKEVQWKM | 571 | P48357 | |
| YAGQFVMEGFLRLRW | 381 | P49279 | |
| LKMSGLRYNEWLQDG | 676 | O75582 | |
| QLAYLWMERQKSGGN | 276 | Q6UVM3 | |
| NGGVRQAYKAYLKWM | 681 | Q495T6 | |
| YAWGKMGSNSEVARL | 16 | P34949 | |
| LANKTSDWLGYMRFL | 646 | Q6VY07 | |
| EKWGLNMEYCRGQAY | 316 | O43422 | |
| LAMWLVNGFQLLYVG | 221 | O76062 | |
| SDMTYGGFNWKLNFR | 251 | Q8IUC8 | |
| NKFYQLMLAWVLVGS | 201 | Q8NH76 | |
| QWSMLGRIKAQAFGF | 36 | Q9BRQ4 | |
| QEYAKRYSWSGMGRI | 131 | Q6ICH7 | |
| NGWFRFILDGKLATM | 691 | Q9ULT8 | |
| QRFYKENLGQGWMTQ | 371 | P07099 | |
| KSGFRGPLNWYRNME | 456 | P34913 | |
| LERGNLMGGWKYSTF | 171 | P23435 | |
| IGFSIRDMWYKLGQN | 1066 | Q92608 | |
| ARLITFGTWMYSVNK | 6 | Q96P09 | |
| FGTWMYSVNKEQLAR | 11 | Q96P09 | |
| LASKDGWVNIMYNGL | 1376 | Q9P0X4 | |
| RLNNSVFQWYGRMGE | 651 | Q8WXX0 | |
| VSYSGLVNDNWKLGM | 176 | A0A0U1RQE8 | |
| TWERLYFFTQGGNLM | 296 | Q8NEU8 | |
| KLYSLGNGRWMLTLA | 371 | P09543 | |
| QWGMNGYFLIERGKN | 306 | P09668 | |
| YLRNFNNWMKSVLIG | 171 | O43148 | |
| WAMLFASGGFQVKLY | 21 | Q9Y2S2 | |
| AVGFSDGYLALWNMK | 236 | Q8WYP5 | |
| FMLLAQLVSGNWYVK | 11 | Q9BYW3 | |
| GFWTLEMFGNQYRAL | 416 | Q8WVV5 | |
| RVYGALMWSLGKIIN | 231 | Q9H4M9 | |
| GQMVLAGLAYGFRNW | 236 | Q9Y226 | |
| LDMYNAVMLGWARQG | 261 | O00411 | |
| ILAWGLRNMKSYQLA | 1336 | O75923 | |
| KWGMEQGRQELYGAL | 91 | P0C7I6 | |
| WRSKILLGLNFYGMD | 291 | Q9BWS9 | |
| LMFSDGGRNWKQYRR | 111 | Q96NU0 | |
| SWYRTFMGIVNLFGL | 11 | Q6ZN68 | |
| GETMIQWSQFKGYFI | 36 | Q9NY27 | |
| NLTGYIWYKGQMRDL | 61 | P11464 | |
| FTWVMGLNYRDGVMQ | 226 | Q6J272 | |
| ILAVWGLGMAYRKNA | 51 | P46019 | |
| LENFKQGRWSNMYKL | 446 | Q68BL7 | |
| NLAGYIWYKGQMKDL | 61 | Q16557 | |
| TGWKNRSVGYTLMNK | 191 | Q9P2E2 | |
| KSNYNLFIEWMAGGS | 1316 | Q13233 | |
| RKGSLEKMNNYWDVG | 436 | Q6ZN16 | |
| SYLQKDGWRYMLGLA | 231 | Q96QE2 | |
| NNDLTMWLGEKLGFY | 476 | Q9H720 | |
| LQGFRVIYWANLMDG | 1121 | O60469 | |
| YLKGMAAAGNYAWVN | 306 | Q9Y3I0 | |
| IRINYLGDWGMQFGL | 166 | Q5T160 | |
| ATWKLQMIYGNGAES | 196 | Q68CJ6 | |
| QLYYMGRWKLDSGIF | 651 | Q8NBJ9 | |
| GRGMTSKQLNNWAVY | 186 | A6NHR9 | |
| WLRMKGKDNFLFITY | 196 | O00204 | |
| YGWRNAMLIQGAVSL | 186 | Q7RTX9 | |
| NGWMIKIGRGLDYFK | 201 | Q8WV92 | |
| DQKLYSSMDFGRRWQ | 316 | Q9UPU3 | |
| NLTGYIWYKGQMTDL | 61 | Q00889 | |
| YQGERVAWYMLAMGQ | 981 | Q9BQS7 | |
| FVALYLQARMKGDWA | 181 | O14494 | |
| FGDMLGSHKWRNNYL | 151 | Q13103 | |
| AVGMNNRAWFYVLGE | 401 | Q8NEZ3 | |
| GYLALLQVATFKGWM | 1406 | Q9NY46 | |
| WQDSFMVARLIGYKT | 501 | Q9HAS3 | |
| RVYGALMWSLGKIVN | 231 | Q9NZN3 | |
| LGAMQVSKYGDLANW | 396 | Q9BYC2 | |
| WIYVFMGNMLRGIGE | 171 | Q9Y6L6 | |
| WNEQFDRKYTRGMLF | 171 | P50452 | |
| GYLSLLQVATFKGWM | 1421 | P35498 | |
| YRLSNLMTAKGWNLN | 461 | O95470 | |
| NLWTMFQAAQKLGGY | 351 | Q14865 | |
| QKREMGASLYVGWAA | 156 | O14493 | |
| WQTYVSGMLRFGKVD | 176 | Q8WUD6 | |
| QYVWDRMLGGFKHKN | 126 | Q7Z460 | |
| TAYLVEKMRGQFGWV | 371 | Q15846 | |
| NKWNTALIGLMTYFR | 1261 | Q6P2Q9 | |
| LNTVWFGQMSGYRRK | 331 | P48995 | |
| MLSKAAQSGQWKYGQ | 76 | Q9UJT1 | |
| QGFWESQMELRKLYG | 61 | P24557 | |
| QKARDTLYMVWGQGR | 141 | Q9H4F1 | |
| AMWTDGRYFLQAAKQ | 71 | Q9NQW7 | |
| GRYFLQAAKQMDSNW | 76 | Q9NQW7 | |
| FYFTQRVVDKLWQGM | 2046 | Q8IZQ1 | |
| IFNGSNWIMLIYKGG | 111 | P20645 | |
| EMQNYRQQKGWAFGS | 541 | Q5PRF9 | |
| IMYSFNKTQGPRALW | 146 | Q96AG3 | |
| LYAASGNAVRMWDLK | 1466 | Q7Z4S6 | |
| GYLALLQVATFKGWM | 1356 | Q9Y5Y9 | |
| MSFVKGWGAEYRRQT | 416 | Q15796 | |
| MKYWGVASFLQKGND | 106 | P02753 | |
| SLYIWTFGVNMKEAA | 141 | Q9UG56 | |
| WIYVFMGNMLRGIGE | 171 | Q9NPD5 | |
| GYLSLLQVATFKGWM | 1411 | Q99250 | |
| IWQSLQGSGKMQYFQ | 1236 | Q8IZH2 | |
| EGFQYFQKAWSSMLR | 876 | Q6P2S7 | |
| FLARLNFIWKGFINM | 1201 | Q92576 | |
| FAWKATAMGKNYVNG | 156 | P25787 | |
| WYNYRQRKSMDSKGQ | 696 | Q9HBX9 | |
| MELVLVKYQGKNWNG | 2711 | Q709C8 | |
| MFLKLNYWNTKIGLQ | 126 | A6NFE2 | |
| AIDYWIFLGLKMGRN | 626 | Q9BQI6 | |
| GLFWANIRAAFNMKL | 771 | Q9Y2C9 | |
| LDQGGFKIYVWQGRM | 286 | O15195 | |
| FKIYVWQGRMSSLQE | 291 | O15195 | |
| IGSMAQRAYWALLNQ | 636 | Q8IUG5 | |
| VGRKQFMRFEWANYA | 841 | Q8IUG5 | |
| KGLMYGGVWATVQFL | 331 | Q8IUH5 | |
| NSMNDGWYGALKEAI | 776 | Q07157 | |
| LYARQGGRRWIKQMF | 346 | Q9HD45 | |
| AYLALLQVATFKGWM | 1246 | Q9UI33 | |
| QKLYLGGASRDFWMS | 116 | Q6P9A1 | |
| ATGMYEQLKGEWNRK | 91 | P48556 | |
| KWMVRAFSGYLATDQ | 446 | Q8N5T2 | |
| VGMNYAFITWLVKSR | 236 | Q9NWC5 | |
| SIGVILNMFFKYTWN | 371 | Q5H9R7 | |
| NLAGYIWYKGQLMDL | 61 | Q15238 | |
| GIIMKALWTGQYRYI | 831 | P40818 | |
| WMNALYFTRGLKLTG | 586 | Q9HBA0 | |
| AKYEWIGQLMGAALR | 596 | Q5T447 | |
| TRVNKGWLYGLRMLQ | 276 | O94898 | |
| MAKAVYGRTFTWLVN | 346 | Q8N1T3 |